Stocks
United Therapeutics CorporationUTHR
NASDAQHealthcareBiotechnology$536.12+0.62%
A biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other rare diseases. Its revenue is largely driven by a portfolio of PAH treatments, while the company invests heavily in next‑generation platforms including organ manufacturing and re...
Market Cap: $23.5B52W Range: $266.98 – $548.12
This page tracks all publicly disclosed congressional trades in United Therapeutics Corporation (UTHR), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 5 purchases and 9 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
14
Unique Politicians
2
Buys
5
Sells
9
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |
| 2025-10-30 | Lisa McClain | buy | $1K – $15K |